Skip to main content
. 2017 Sep 13;31(15):2095–2106. doi: 10.1097/QAD.0000000000001594

Fig. 2.

Baseline demographics: verification that inverse probability of treatment weighting achieves baseline covariate balance between regimens.

Fig. 2

ATV, atazanavir; CAD/CVD, coronary artery disease/cerebrovascular disease; eGFR, estimated glomerular filtration rate; INSTI, integrase strand transfer inhibitor; IPT, inverse probability of treatment; NNRTI, nonnucleoside reverse transcriptase inhibitor; PCI/CABG, percutaneous coronary intervention/coronary artery bypass graft; PI, protease inhibitor.